CCO Oncology Podcast

189 Episoder

1. MET Exon 14 Mutation–Positive NSCLC: FAQ Part 2

   Publisert: 28.8.2020
2. Immunotherapy in SCLC: FAQ on Current Best Practice and Emerging Therapeutic Strategies

   Publisert: 27.8.2020
3. Application of New Data in B-Cell Malignancies From ASCO and EHA 2020: CLL

   Publisert: 26.8.2020
4. Future Treatment Strategies for Acute Myeloid Leukemia—Emerging Targeted Therapy Combinations and Beyond

   Publisert: 14.8.2020
5. Tumor Agnostic TRK Inhibitor Therapy and NTRK Fusion Testing: Experts Answer Clinician Questions

   Publisert: 14.8.2020
6. Improving Outcomes for Patients With CML With TKIs: FAQ Podcast

   Publisert: 13.8.2020
7. Precision Therapy in Lung Cancer: FAQ on Biomarker Testing and Targeted Therapies

   Publisert: 10.8.2020
8. Application of Existing and Emerging Biomarkers for Immuno-Oncology Across Tumor Types: Answering Clinician Questions

   Publisert: 10.8.2020
9. Precision Therapy in Lung Cancer: FAQ on Biomarkers for Immune Checkpoint Inhibitors

   Publisert: 10.8.2020